Other Books of Interest

The Dawn of Drug Safety

Myles Stephens
Published by George Mann Publications, Supplied by UMC
First published in May 2010; 2nd edition, 2012. The 3rd and final edition is presented here for download in pdf format (click on front cover image below).

The author writes, ‘This is not a history book, but rather a scientific account of the evidence concerning the adverse effects of herbs and drugs prior to and including the thalidomide disaster.’

The book is in four parts:
• a chronological account of the discovery, reporting and management of the adverse reactions to medicines in the context of important contemporary medical events, from the beginning of time until the thalidomide disaster.
• an analysis of six marker drugs representing typical medicines covering a period of over 3,000 years: hellebore, henbane, mercury, opium, aspirin and streptomycin.
• an analysis of the fifty drugs that had been on the market prior to 1960 and which have been either withdrawn or restricted because of one or more adverse reactions.
• a discussion, and lessons from this experience.

A Lifetime in Safety

The writings of Ed Napke
Published by UMC
Canada’s ‘Dr Safety,’ Ed Napke founded the country’s ADR monitoring programme in the 1960s and was a pioneer in many aspects of pharmacovigilance thinking and practice. This is a collection of his many published articles, often provocative and controversial, covering much of his lifetime’s work. Among many other achievements, he is remembered for his pre-computer pigeon-hole data-storage system, and his insistence that excipients should always be considered as part of the safety profile of medicines. The book includes an introduction by Dr Napke.
Please contact: info@who-umc.org for more information

Writings on Pharmacovigilance

Selected articles by Prof. David Finney
Published by UMC (out of print, pdf available)

Many activities of the WHO Medicines Safety Programme have developed from the original ideas and work of Professor David Finney and his contemporaries. The progress in semi-automated signal detection, in recognizing broader patient safety concerns, development of terminology and post-marketing surveillance are among many examples.

The UMC re-published the key ideas and thoughts of David Finney in a volume of 23 papers published over 40 years, tracing his involvement with ADR monitoring and the growth of pharmacovigilance.

A pdf of the book (32Mb) is available from UMC - please contact info@who-umc.org to be sent a copy.

Drugs and Bugs - A little book about medicines

Fredrik Brounéus and Nina Erixon-Lindroth
Latest edition from UMC

A charming, informative book for children, extensively illustrated. It tells the story of how viruses, bacteria, fungi and parasites attack the body and how medicines work.
Please contact: info@who-umc.org for more information

Just a little white sleeping pill - The story of the Neurosedyn catastrophe

Nadja Yllner
Published by Recito 
A comprehensive and radical account of the thalidomide disaster and its tragic aftermath.
There are a few remaining copies, but not easy to find.
Please contact: info@who-umc.org for more information

Farmacovigilancia, hacia una mayor seguridad en el uso de los medicamentos: Temas prácticos en Farmacovigilancia

(Pharmacovigilance, towards a safer use of medicines)
Authors include: Luis Alesso (editor), Inés Bignone, Raquel Herrera Comoglio (editor), Bruce Hugman, Judith K. Jones, Marie Lindquist, Ronald Meyboom and others.
2nd edition completely revised and much expanded (300 pages).
A comprehensive introduction to pharmacovigilance in Spanish.
Chapters include: • La Farmacovigilancia en el proceso de seguridad de los medicamentos; • Monitorización espontánea: pasado y futuro; •Algunos casos en la historia de la Farmacovigilancia; •Reacciones adversas a medicamentos; •Interacciones farmacológicas; •Interacciones de especial importancia clínica; •Evaluación de la causalidad en farmacovigilancia; •Detección de la señal en farmacovigilancia; •Detección y verificación de problemas de seguridad de medicamentos; •Biodisponibilidad y bioequivalencia; •El Programa Internacional de Farmacovigilancia de la OMS; •Comunicación en Farmacovigilancia.
Download pdf here

For information on obtaining paper-print copies please contact: info@who-umc.org


Read more

Last modified on: January 24, 2017